These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 16706823)
1. Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C. Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):122-8. PubMed ID: 16706823 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. Tokita H; Fukui H; Tanaka A; Kamitsukasa H; Yagura M; Harada H; Okamoto H J Gastroenterol Hepatol; 2005 May; 20(5):752-8. PubMed ID: 15853990 [TBL] [Abstract][Full Text] [Related]
3. Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C. De Mitri MS; Morsica G; Chen CH; Mele L; Baccarini P; Chianese R; Piccinini A; Lazzarin A; Pisi E Ital J Gastroenterol Hepatol; 1997 Jun; 29(3):255-61. PubMed ID: 9646218 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. Makiyama A; Itoh Y; Kasahara A; Imai Y; Kawata S; Yoshioka K; Tsubouchi H; Kiyosawa K; Kakumu S; Okita K; Hayashi N; Okanoue T Cancer; 2004 Oct; 101(7):1616-22. PubMed ID: 15378504 [TBL] [Abstract][Full Text] [Related]
5. Characterization of hepatocellular carcinoma developed after achieving sustained virological response to interferon therapy for hepatitis C. Sanefuji K; Kayashima H; Iguchi T; Sugimachi K; Yamashita Y; Yoshizumi T; Soejima Y; Nishizaki T; Taketomi A; Maehara Y J Surg Oncol; 2009 Jan; 99(1):32-7. PubMed ID: 18985618 [TBL] [Abstract][Full Text] [Related]
6. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT. Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015 [TBL] [Abstract][Full Text] [Related]
7. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon. Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398 [TBL] [Abstract][Full Text] [Related]
9. Interferon therapy does not prevent hepatocellular carcinoma in HCV compensated cirrhosis. Testino G; Ansaldi F; Andorno E; Ravetti GL; Ferro C; De Iaco F; Icardi G; Valente U Hepatogastroenterology; 2002; 49(48):1636-8. PubMed ID: 12397752 [TBL] [Abstract][Full Text] [Related]
10. [The effect of iron depletion on the response to interferon treatment in patients with chronic hepatitis C. Pilot study]. Ortiz V; Olaso V; López Viedma B; Córdoba J; Molina JM; Lainez B; Pastor M; Berenguer J Gastroenterol Hepatol; 1999 Mar; 22(3):122-6. PubMed ID: 10228321 [TBL] [Abstract][Full Text] [Related]
11. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response. Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242 [TBL] [Abstract][Full Text] [Related]
12. Resected cases of hepatocellular carcinoma detected after interferon therapy for chronic hepatitis C. Kubo S; Nishiguchi S; Tamori A; Hirohashi K; Tanaka H; Tsukamoto T; Shuto T; Kuroki T; Kinoshita H Hepatogastroenterology; 2000; 47(34):1100-2. PubMed ID: 11020887 [TBL] [Abstract][Full Text] [Related]
13. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
14. Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy. Akuta N; Suzuki F; Hirakawa M; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kumada H J Med Virol; 2011 Jun; 83(6):1016-22. PubMed ID: 21503914 [TBL] [Abstract][Full Text] [Related]
15. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients. Kobayashi S; Takeda T; Enomoto M; Tamori A; Kawada N; Habu D; Sakaguchi H; Kuroda T; Kioka K; Kim SR; Kanno T; Ueda T; Hirano M; Fujimoto S; Jomura H; Nishiguchi S; Seki S Liver Int; 2007 Mar; 27(2):186-91. PubMed ID: 17311612 [TBL] [Abstract][Full Text] [Related]
16. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587 [TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C. Scherzer TM; Reddy KR; Wrba F; Hofer H; Staufer K; Steindl-Munda P; Gangl A; Ferenci P J Viral Hepat; 2008 Sep; 15(9):659-65. PubMed ID: 18637075 [TBL] [Abstract][Full Text] [Related]
18. Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection. Castillo I; Bartolomé J; Quiroga JA; Barril G; Carreño V Aliment Pharmacol Ther; 2009 Sep; 30(5):477-86. PubMed ID: 19523175 [TBL] [Abstract][Full Text] [Related]
19. Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group. Bernardinello E; Cavalletto L; Chemello L; Mezzocolli I; Donada C; Benvegnú L; Merkel C; Gatta A; Alberti A Hepatogastroenterology; 1999; 46(30):3216-22. PubMed ID: 10626189 [TBL] [Abstract][Full Text] [Related]
20. Necessities of interferon therapy in elderly patients with chronic hepatitis C. Ikeda K; Arase Y; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Saitoh S; Suzuki F; Suzuki Y; Kumada H Am J Med; 2009 May; 122(5):479-86. PubMed ID: 19375558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]